Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$128.91 - $192.44 $113,054 - $168,769
-877 Reduced 10.93%
7,147 $981,000
Q2 2023

Aug 11, 2023

SELL
$183.43 - $232.67 $104,555 - $132,621
-570 Reduced 6.63%
8,024 $1.5 Million
Q1 2023

May 11, 2023

SELL
$193.75 - $232.55 $372,581 - $447,193
-1,923 Reduced 18.28%
8,594 $2 Million
Q4 2022

Feb 09, 2023

SELL
$187.24 - $242.74 $4.46 Million - $5.79 Million
-23,841 Reduced 69.39%
10,517 $2.13 Million
Q3 2022

Nov 09, 2022

SELL
$177.23 - $227.44 $113,781 - $146,016
-642 Reduced 1.83%
34,358 $6.56 Million
Q2 2022

Aug 12, 2022

BUY
$181.58 - $368.0 $244,406 - $495,328
1,346 Added 4.0%
35,000 $6.45 Million
Q1 2022

May 12, 2022

SELL
$303.87 - $423.8 $620,502 - $865,399
-2,042 Reduced 5.72%
33,654 $11.8 Million
Q4 2021

Feb 10, 2022

BUY
$347.28 - $421.83 $625,104 - $759,294
1,800 Added 5.31%
35,696 $13.6 Million
Q2 2021

Aug 09, 2021

SELL
$372.84 - $481.5 $84,261 - $108,819
-226 Reduced 0.66%
33,896 $16 Million
Q1 2021

May 13, 2021

SELL
$361.28 - $504.76 $1.31 Million - $1.83 Million
-3,635 Reduced 9.63%
34,122 $13.1 Million
Q4 2020

Feb 12, 2021

BUY
$292.7 - $370.96 $351,240 - $445,152
1,200 Added 3.28%
37,757 $14 Million
Q1 2020

May 15, 2020

BUY
$209.2 - $335.53 $71,128 - $114,080
340 Added 0.94%
36,557 $9.98 Million
Q4 2019

Feb 13, 2020

SELL
$288.29 - $335.49 $1,441 - $1,677
-5 Reduced 0.01%
36,217 $12 Million
Q3 2019

Nov 12, 2019

BUY
$266.84 - $378.23 $301,529 - $427,399
1,130 Added 3.22%
36,222 $11 Million
Q2 2019

Aug 09, 2019

BUY
$300.59 - $368.15 $8.73 Million - $10.7 Million
29,057 Added 481.47%
35,092 $12.9 Million
Q3 2018

Nov 13, 2018

SELL
$279.04 - $367.06 $325,081 - $427,624
-1,165 Reduced 16.18%
6,035 $2.22 Million
Q2 2017

Aug 18, 2017

BUY
N/A
7,200
7,200 $1.25 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Oak Associates LTD Portfolio

Follow Oak Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Associates LTD , based on Form 13F filings with the SEC.

News

Stay updated on Oak Associates LTD with notifications on news.